University Health Network, Toronto: Sarcoma trials
The registry lists 18 Sarcoma studies with University Health Network, Toronto as lead sponsor. 7 are open to participants now and 1 have results posted.
Phase 1 6Phase 2 6No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- BOLD-100 Plus Doxorubicin in Advanced Soft Tissue SarcomasNot yet recruitingNCT07027423Phase 1
- A Trial of ABSK043, an Oral PD-L1 Inhibitor, in Patients With Angiogenic SarcomasRecruitingNCT07014137Phase 2
- BAL Fluid Biomarkers in SarcomaRecruitingNCT06815666Phase 2
- Digital Peer Navigation for Adolescents and Young Adults With CancerRecruitingNCT06193369Not applicable
- IVIM & OLINK in SarcomaRecruitingNCT05950594Phase 2
- Circulating Tumor DNA in Soft Tissue SarcomaRecruitingNCT03818412Not applicable
- In Vivo Lung Perfusion for Pulmonary Metastases of SarcomaRecruitingNCT02811523Phase 1
- Study of ENMD-2076 in Patients With Advanced/Metastatic Soft Tissue SarcomaCompletedNCT01719744Phase 2Results posted
- A Study of Different Dosing Schedules of Selinexor in Sarcoma PatientsCompletedNCT04811196Phase 1
- Prehabilitation to Improve Cancer Surgery Outcomes in AYA Patients With Extremity SarcomasCompletedNCT04248959Not applicable
- The PET- Retroperitoneal Sarcoma StudyCompletedNCT04224948Not applicable
- FAZA PET/MRI SarcomaActive, not recruitingNCT03418818Not applicable
- Study of Selinexor and Doxorubicin in Advanced Soft Tissue SarcomasCompletedNCT03042819Phase 1
- Evaluating Bacterial Response in Sarcoma Management Using Fluorescence ImagingCompletedNCT02270086
- High Precision RT For Soft-Tissue SarcomaCompletedNCT01389050Phase 2
- Study of Low Dose CT in Sarcoma PatientsCompletedNCT00188422Phase 1
- IMRT Lower Limb Soft Tissue SarcomaCompletedNCT00188175Phase 2
- EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue SarcomaTerminatedNCT00004261Phase 1